Umbilical & Placental Cell News

Noncanonical Enhancers Control Gene Expression and Cell Fate in Human Pluripotent Stem Cells

[Science Advances] Researchers combined massively parallel enhancer assays with chromatin structure and transcriptome profiling to functionally annotate enhancers genome-wide in hiPSC.

Acute Degradation of Pumilio Proteins Reveals a Biphasic Posttranscriptional Regulatory Hierarchy in Embryonic Stem Cell Fate Decision

[Proceedings of the National Academy of Sciences of the United States of America] Using acute protein degradation systems combined with time-resolved RNA sequencing, and enhanced crosslinking and immunoprecipitation, investigators delineated a two-phase regulatory hierarchy modulated by Pumilio proteins Pum1/2 in mouse ESCs.

Forward Programming of Human Pluripotent Stem Cells to Endothelial Cells Utilizing ETV2-mRNA Delivery with Ionizable Lipid Nanoparticles

[Acta Biomaterialia] The authors described a non-integrating approach that utilizes ionizable lipid nanoparticles to deliver mRNA encoding the ETV2 transcription factor to efficiently forward reprogram hPSCs to endothelial cells.

NANOG and OCT4 Dosage Shapes Non-Monotonic Gene Expression Responses during Stem Cell Differentiation

[Cell Reports] Researchers employed hESCs as a dynamic model to study gene dosage effects and systematically titrated key transcription factors NANOG and OCT4 expression using CRISPR interference.

PIWIL2 Suppresses Pluripotency in the Male Mouse Germline

[EMBO Reports] Investigators identified the protein P-element-induced wimpy testis (PIWI)L2 as a key suppressor of pluripotency in the male germline. Although transposon silencing is the best-established function of piwi-interacting RNAs (piRNAs), they hypothesized that piRNAs might also suppress pluripotency.

A HERV Transcriptional Signature of Cellular Aging Persists after iPSC Reprogramming

[Virologica Sinica] Using a multi-stage system spanning hESCs, young and replicatively senescent hESC-derived mesenchymal progenitor cells (MPCs), and their reprogrammed iPSCs, scientists defined a six-element candidate robust senescence-associated human endogenous retrovirus (HERV) signature.

Generation of Xeno- and Feeder-Free Pluripotent Stem Cell-Derived Trabecular Meshwork-Like Cells

[Experimental Cell Research] Investigators reported the development of a xeno- and feeder-free approach to generate functional trabecular meshwork (TM)-like cells from hESCs. Using recombinant growth factors, hESCs were differentiated into neural crest cells and subsequently into TM-like cells over 35 days.

ZSCAN4 Links a Transient Reset of Repetitive DNA to Genome Integrity and Cellular Plasticity

[Science Advances] The authors synthesize recent advances to propose a unifying framework in which ZSCAN4 orchestrates controlled genome instability to facilitate plasticity while safeguarding long-term genomic integrity.

Pathogenic Protein Transmission in Induced Pluripotent Stem Cell-Derived Neural Models: From Cells to Organoids

[Neural Regeneration Research] Scientists aim to summarize the application of hiPSC–derived systems for investigating misfolded protein aggregation and intercellular propagation in neurodegenerative disease.

Promega Enters License Agreement with BrainXell to Implement NanoLuc®, NanoBiT® and HaloTag® Technologies in iPSC-Derived Models

[Promega Corporation] Promega Corporation has signed a license agreement with BrainXell, Inc., a producer of iPSC-derived human cells such as neurons and glia. Under the agreement, BrainXell is authorized to engineer HaloTag®, NanoLuc®, and NanoBiT® technologies into iPSC lines and iPSC-derived models of the central nervous system.

Evotec Secures $2.9 Million Grant to Advance Early Drug Safety Testing Using Human Stem Cell Technology

[Evotec SE] Evotec SE announced that it has been awarded a new $2.9 million grant by the Gates Foundation to support continued use of its human stem cell-based New Approach Methodologies for identifying potential safety risks to fetal development in novel drug candidates.

The Pancreatic Cancer Secretome Activates the STAT3 Signaling in Pancreatic Stellate Cells to Drive the Secretion of Muscle Atrophy-Inducing Factors

[Scientific Reports] Scientists treated pancreatic stellate cells with conditioned medium from various pancreatic cancer cells (CCM). They revealed that CCM consistently activates STAT3 to secrete muscle atrophy-inducing factors from stellate cells and that the secretion was not observed when CCM from brefeldin A-treated cancer cells was added.
spot_img